What's New
| CE Education The Treatment of R/R cHL in the Era of Checkpoint Inhibitors Catherine Diefenbach, MD |
| Continuing Education for Nurses Evolving Care Strategies in Newly Diagnosed HL: Emerging Therapies and the Changing Role of the Oncology Nurse Amy L. Goodrich, RN, MSN, CRNP; Mollie E. Moran, MSN, CNP, AOCNP |
| CE Education Advanced-stage cHL: Rethinking Our Options in Frontline Therapy Jonathon B. Cohen, MD, MS |
| CE Education Individualized Treatment Approaches in Patients with Newly Diagnosed Hodgkin Lymphoma Alison J. Moskowitz, MD |
| FAQ Library Determining prognostic risk when treating patients who are newly diagnosed with HL Alison J. Moskowitz, MD |